• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antimicrob Agents Chemother. OXA-235, a novel Class D Beta-Lactamase Involved in Resistance to Carbapenems in Acinetobacter baumannii

Giuseppe

Emeritus
[Source: Antimicrobial Agents and Chemotherapy, full page: (LINK). Abstract, edited.]

OXA-235, a novel Class D Beta-Lactamase Involved in Resistance to Carbapenems in Acinetobacter baumannii [PublishAheadOfPrint]

Higgins, P. G., Perez-Llarena, F. J., Zander, E., Fernandez, A., Bou, G., Seifert, H.



We investigated the mechanism of carbapenem resistance in 10 Acinetobacter baumannii strains isolated from the United States and Mexico between 2005 and 2009. Detection of known metallo-beta-lactamase or carbapenem-hydrolyzing oxacillinase (OXA) genes by PCR was negative. Presence of plasmid encoded carbapenem-resistance genes was investigated by transformation of A. baumannii ATCC 17978. Shotgun cloning experiments and sequencing were performed followed by expression of novel beta-lactamase in A. baumannii. Three novel OXA enzymes were identified; OXA-235 in 8 isolates and the amino acid variants OXA-236 (Glu173-Val) and OXA-237 (Asp208-Gly) were found in 1 isolate each. The deduced amino acid sequence shared 85% identity with OXA-134, 54%-57% identity with the acquired OXA-23, OXA-24, OXA-58, and OXA-143, and 56% identity with the intrinsic OXA-51, and thus represent a novel subclass of OXA. Expression of OXA-235 in A. baumannii led to reduced carbapenem susceptibility while cephalosporin MICs were unaffected. Genetic analysis revealed that bla<SUB>OXA-235</SUB>, bla<SUB>OXA-236</SUB> and bla<SUB>OXA-237</SUB> were bracketed between two ISAba1 insertion sequences. In addition, presence of these acquired beta-lactamase genes might result from a transposition-mediated mechanism. This highlights the propensity of A. baumannii to acquire multiple carbapenem-resistance determinants.
-
------
 
Back
Top Bottom